IN PARTNERSHIP


“Each clinical trial has its own unique complexities. It’s vital to consider multiple options in order to choose the most efficient and cost-effective route to source comparators.”


• not having access to global suppliers in order to ethically source the product in the desired quantity


• complying with country-specific regulations and gaining market approval, making it challenging to deliver the comparator within the study time frame


• comparator drugs are in high demand and more expensive than placebos, meaning it can be difficult to remain on budget. These supply chain inefficiencies can prove


very expensive and, more importantly, put patient safety at risk. The comparator sourcing supply chain requires expert planning and management to ensure successful delivery. An efficient comparator sourcing strategy helps to shorten the supply chain process, minimise risk and maximise cost savings.


Checklist for an effective comparator sourcing strategy Working with a comparator sourcing partner such as Clinical Services International (CSI) will streamline your clinical trial supply chain and ensure high-quality comparator drugs are sourced in a timely and cost-effective manner. As a strategic comparator sourcing partner, we


product. In order to keep up with the inflated demand, clinical trial sponsors are turning to global markets to source comparators and clinical trial supplies. However, with globalisation come a number of challenges that can delay clinical trial supply timelines and increase costs, including:


C


linical trials are increasingly using comparator drugs over placebos when investigating the efficacy of a new


take a step back and look at the bigger picture, to gather all of the relevant information during the clinical trial supply planning process. We consider a list of initial questions when beginning a project in order to understand the comparator requirements. After the answers to these questions have been thought through, we can develop a comparator sourcing strategy that ensures product quality, safety and security standards are adhered to at every stage of the trial within stringent budgets and timelines.


Protocol analysis: • Which comparator drug is required? • What quantity of the comparator is


Outsourcing in Clinical Trials Handbook | 17


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100